Insomnia
RecruitingStudy of tasimelteon compared to placebo for treating insomnia in children
- Disease:Insomnia
- Substances:Tasimelteon
Germany- Participants:0–17 years
- Substances:Tasimelteon
- Sponsor:Vanda Pharmaceuticals Inc.
Rare diseases
Investigational molecules
Locations

2200 Pennsylvania Avenue Northwest Suite 300, 20037-1709, United States
Clinical research includes Delayed Sleep-Wake Phase Disorder, Non-24 Hour Sleep-Wake Disorder, and insomnia disorder, with attention to circadian timing, sleep onset, and maintenance of regular sleep patterns.
The sponsor’s portfolio in this area centers on sleep regulation and the management of disrupted circadian rhythm alignment.
Vanda Pharmaceuticals Inc. runs clinical trials in conditions such as Insomnia, Impaired gastric emptying, Diabetic gastroparesis, Circadian rhythm sleep disorder, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Germany
France
Belgium
AustriaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.